1.Mammary fibroadenoma in a lamb.
M Yavuz GULBAHAR ; Tolga GUVENC ; Murat YARIM ; Yonca B KABAK ; Yuksel SOZGEN
Journal of Veterinary Science 2007;8(4):423-425
A fibroadenoma was diagnosed in the left udder of a 3-month-old female Chios lamb. No recurrence was observed after surgery. Grossly, the tumor had a whitishgray lobular appearance, and the lobules were interlaced with thin septa. Microscopically, the tumor was composed of proliferating fibroepithelial tissue, including differentiated ducts lined by whorls and interlacing bundles of abundant loose fibrovascular stroma. Immunohistochemistry revealed the ductal epithelium to be positive for pancytokeratin (AE1/AE3) and loose fibrovascular stroma was positive for vimentin and basal cells covering the ductal epithelium of alpha-smooth-muscle actin. Immunostaining for the estrogen and progesterone receptors was negative. A diagnosis of mammary fibroadenoma was made based on the histological and immunohistochemical findings.
Animals
;
Female
;
Fibroadenoma/pathology/*veterinary
;
Keratins/metabolism
;
Mammary Glands, Animal/*pathology
;
Mammary Neoplasms, Animal/*pathology
;
Sheep
;
Sheep Diseases/*pathology
;
Vimentin/metabolism
2.Spectrum of Axillary Disorders (Excluding Metastasis from Breast Cancer): Radiological and Pathological Correlation: A Pictorial Essay.
Ho Jun KIM ; Keum Won KIM ; Yong Sung PARK ; Dong Jin CHUNG ; Young Jun CHO ; Cheol Mog HWANG ; Hyeun Mi YOO ; Yoon Mee KIM ; Mee Ran LEE
Journal of the Korean Radiological Society 2007;57(6):583-594
Axillary disorders originate from an axillary lymph node, subcutaneous fat layer, accessory breast, nerve, vessel and muscle. The most common causes of a palpable axillary mass are a lymph node pathology containing a benign axillary lymphadenopathy, and malignant lymph nodes such as a metastatic lymphadenopathy from breast cancer and a malignant lymphoma. For the detection of masses in the axilla, mammography and sonography are the imaging modalities of choice. We present a spectrum of various axillary masses with correlative radiological imaging and pathological findings in this pictorial essay. Knowledge of the radiological findings of various axillary disorders is useful for a differential diagnosis and for preventing unnecessary invasive procedures.
Animals
;
Axilla
;
Breast Neoplasms
;
Breast*
;
Diagnosis, Differential
;
Lymph Nodes
;
Lymphatic Diseases
;
Lymphatic Metastasis
;
Lymphatic System
;
Lymphoma
;
Mammary Neoplasms, Animal
;
Mammography
;
Neoplasm Metastasis*
;
Pathology
;
Radiography
;
Subcutaneous Fat
;
Ultrasonography
3.Effect of Antioxidants on the Incidence of 7, 12-dimethylbenzanthracene-induced Mammary Tumor in Rats.
Yonsei Medical Journal 1984;25(1):39-45
The inhibitory effect of selenium, vitamin E, and BHA on DMBA-induced mammary tumorigenesis in rats was investigated. Dietary vitamin E (200 IU/Kg diet) alone could not reduce the tumor incidence at 25 weeks after DMBA administration (10mg DMBA/rat) when selenium was deficient. Selenium supplementation (2ppm in drinking water) to rats fed a practical diet (0.17 ppm Se) reduced the tumor incidence to 14.3% from 75% at 27 weeks after DMBA administration. Dietary supplementation of BHA (0.75%) also reduced the incidence of DMBA-induced mammary tumor to 42.9% at 27 weeks after DMBA-treatment. Rats fed a diet deficient in both selenium and vitamin E contained significantly lower glutathione peroxidase activity and higher malondialdehyde in muscle. However, supplementation of selenium or BHA to the rats fed a practical diet did not alter the malondialdehyde content and glutathione peroxidase activities in muscle, skin and mammary gland. Dietary selenium increased the tissue selenium level. DMBA-induced mammary tumorigenesis was reduced by antioxidants tested but the anticarcinogenic effect of selenium or BHA seems to be independent of glutathione peroxi-dase activity.
9,10-Dimethyl-1,2-benzanthracene
;
Animal
;
Antioxidants/pharmacology*
;
Butylated Hydroxyanisole/pharmacology
;
Female
;
Mammary Neoplasms, Experimental/pathology*
;
Rats
;
Selenium/pharmacology
;
Vitamin E/pharmacology
4.Effect of Sangu Decoction () on metastatic bone destruction in rats with mammary cancer.
Bo DENG ; Li-Qun JIA ; Fu-Yun GAO ; Jian CUI ; Huan LI
Chinese journal of integrative medicine 2012;18(4):304-307
OBJECTIVETo study and evaluate the effect of Sangu Decoction (SGD, ) on the bone destruction due to mammary cancer metastasis.
METHODSMetastasis rat mammary tumor-1 cells were transplanted into the left hind limb tibia of SD rats to establish the bone metastasis of the mammary cancer model. The modeled rats were treated with SGD for observing its effect on rats' pain behavior, including 50% paw withdrawal threshold (50% PWT) after von Frey fiber stimulation, burden difference of bilateral feet, and thermal withdrawal latency (TWL), with zoledronic acid as the positive control. Moreover, the damage in the tibia sample of rats was scored by an iconographic method, and the bone mineral density (BMD) as well as the bone mineral content (BMC) were estimated.
RESULTSThe model established showed characteristics of mixed metastasis, revealing the manifestations of tumor development, bone destruction, cancerous pain, etc. In the SGD-treated group, 50% PWT was prolonged (8.13 ± 4.76 vs. 2.30 ± 2.19), and TWL was longer (3.48 ± 0.62 s vs. 2.89 ± 0.26 s) than those in the control group, respectively (P<0.05 or P<0.01). Iconographic scoring also showed improvement of BMD (0.134 ± 0.009 vs. 0.120 ± 0.007, P<0.01) and an elevating trend of BMC in the SGD-treated group.
CONCLUSIONSGD could effectively alleviate the cancerous pain of bone metastasis and mitigate the metastasis that cause osteolytic destruction of bone.
Animals ; Bone Density ; drug effects ; Bone Neoplasms ; drug therapy ; physiopathology ; secondary ; Bone and Bones ; drug effects ; pathology ; physiopathology ; Drugs, Chinese Herbal ; pharmacology ; therapeutic use ; Female ; Mammary Neoplasms, Animal ; pathology ; Rats ; Rats, Sprague-Dawley ; Reaction Time ; drug effects
5.Interferon-γ regulates cell malignant growth via the c-Abl/HDAC2 signaling pathway in mammary epithelial cells.
Wen-Bo REN ; Xiao-Jing XIA ; Jing HUANG ; Wen-Fei GUO ; Yan-Yi CHE ; Ting-Hao HUANG ; Lian-Cheng LEI
Journal of Zhejiang University. Science. B 2019;20(1):39-48
Interferon-γ (IFN-γ) has been used to control cancers in clinical treatment. However, an increasing number of reports have suggested that in some cases effectiveness declines after a long treatment period, the reason being unclear. We have reported previously that long-term IFN-γ treatment induces malignant transformation of healthy lactating bovine mammary epithelial cells (BMECs) in vitro. In this study, we investigated the mechanisms underlying the malignant proliferation of BMECs under IFN-γ treatment. The primary BMECs used in this study were stimulated by IFN-γ (10 ng/mL) for a long term to promote malignancy. We observed that IFN-γ could promote malignant cell proliferation, increase the expression of cyclin D1/cyclin-dependent kinase 4 (CDK4), decrease the expression of p21, and upregulate the expression of cellular-abelsongene (c-Abl) and histone deacetylase 2 (HDAC2). The HDAC2 inhibitor, valproate (VPA) and the c-Abl inhibitor, imatinib, lowered the expression level of cyclin D1/CDK4, and increased the expression level of p21, leading to an inhibitory effect on IFN-γ-induced malignant cell growth. When c-Abl was downregulated, the HDAC2 level was also decreased by promoted proteasome degradation. These data suggest that IFN-γ promotes the growth of malignant BMECs through the c-Abl/HDAC2 signaling pathway. Our findings suggest that long-term application of IFN-γ may be closely associated with the promotion of cell growth and even the carcinogenesis of breast cancer.
Animals
;
Carcinogenesis/pathology*
;
Cattle
;
Cell Cycle Proteins/metabolism*
;
Cell Proliferation/drug effects*
;
Cell Transformation, Neoplastic/pathology*
;
Cells, Cultured
;
Epithelial Cells/pathology*
;
Female
;
Histone Deacetylase 2/metabolism*
;
Imatinib Mesylate/pharmacology*
;
Interferon-gamma/pharmacology*
;
Mammary Glands, Animal/pathology*
;
Mammary Neoplasms, Experimental/pathology*
;
Proto-Oncogene Proteins c-abl/metabolism*
;
Signal Transduction
;
Valproic Acid/pharmacology*
7.The role of maintenance proteins in the preservation of epithelial cell identity during mammary gland remodeling and breast cancer initiation.
Chinese Journal of Cancer 2014;33(2):51-67
During normal postnatal mammary gland development and adult remodeling related to the menstrual cycle, pregnancy, and lactation, ovarian hormones and peptide growth factors contribute to the delineation of a definite epithelial cell identity. This identity is maintained during cell replication in a heritable but DNA-independent manner. The preservation of cell identity is fundamental, especially when cells must undergo changes in response to intrinsic and extrinsic signals. The maintenance proteins, which are required for cell identity preservation, act epigenetically by regulating gene expression through DNA methylation, histone modification, and chromatin remodeling. Among the maintenance proteins, the Trithorax (TrxG) and Polycomb (PcG) group proteins are the best characterized. In this review, we summarize the structures and activities of the TrxG and PcG complexes and describe their pivotal roles in nuclear estrogen receptor activity. In addition, we provide evidence that perturbations in these epigenetic regulators are involved in disrupting epithelial cell identity, mammary gland remodeling, and breast cancer initiation.
Animals
;
Breast Neoplasms
;
genetics
;
pathology
;
physiopathology
;
Cell Transformation, Neoplastic
;
Chromatin
;
genetics
;
metabolism
;
Epigenesis, Genetic
;
physiology
;
Epithelial Cells
;
cytology
;
Female
;
Gene Expression Profiling
;
Gene Expression Regulation, Developmental
;
Histone-Lysine N-Methyltransferase
;
Humans
;
Mammary Glands, Animal
;
cytology
;
growth & development
;
Mammary Glands, Human
;
cytology
;
growth & development
;
Myeloid-Lymphoid Leukemia Protein
;
genetics
;
physiology
;
Polycomb-Group Proteins
;
genetics
;
physiology
;
Receptors, Estrogen
;
metabolism
8.Establishment of a whole-body visualization model of breast cancer with high hepatic metastatic potential in nude mice through serial passage in vivo.
Min YANG ; Zhao-Hui YANG ; Zhi-Dian HOU ; Xue-Nong LI
Journal of Southern Medical University 2008;28(6):944-947
OBJECTIVETo establish a whole-body visualization model of breast cancer with high hepatic metastatic potential in nude mice and observe the development and metastasis of breast cancer by real-time imaging.
METHODSpEGFP-N1 plasmid was transfected into human breast cancer cell line MDA-MB-231 to obtain pEGFP-MDA-MB-231 cells that emitted fluorescence. pEGFP-MDA-MB-231 cells were inoculated orthotopically in BALB/C nude mice and cultured in vivo through serial passage, thereby establishing the mouse model bearing tumors with high hepatic metastasis potential. The fluorescence emitted from the tumors was quantitatively detected and imaged with a fluorescence stereo microscope for real-time visualization of the tumor growth and metastasis.
RESULTSThe transfected breast cancer cells stably and efficiently expressed EGFP. After inoculation of the transfected cells in nude mice, 20% of the first-generation cells showed hepatic metastasis, and the rate increased to 80% among the second-generation and up to 100% among the third-generation cells. The reliability of this visualization model was validated with conventional pathological methods.
CONCLUSIONThe whole-body visualization model bearing breast cancer with high hepatic metastasis potential provides a reliable means for studying the mechanisms of hepatic tumor metastasis, and can be instrumental in the exploration of novel means for breast cancer treatment.
Animals ; Breast Neoplasms ; genetics ; metabolism ; pathology ; Cell Line, Tumor ; Disease Models, Animal ; Female ; Green Fluorescent Proteins ; genetics ; metabolism ; Humans ; Liver Neoplasms ; genetics ; metabolism ; secondary ; Mammary Neoplasms, Experimental ; genetics ; metabolism ; pathology ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Microscopy, Fluorescence ; Neoplasm Transplantation ; Transplantation, Heterologous
9.Chemoprevention of Mammary, Cervix and Nervous system Carcinogenesis in Animals using Cultured Panax ginseng Drugs and Preliminary Clinical Trials in Patients with Precancerous Lesions of the Esophagus and Endometrium.
Vladimir G BESPALOV ; Valeriy A ALEXANDROV ; Andrey Y LIMARENKO ; Boris O VOYTENKOV ; Valeriy B OKULOV ; Mels K KABULOV ; Alexander P PERESUNKO ; Larisa I SLEPYAN ; Viktor V DAVYDOV
Journal of Korean Medical Science 2001;16(Suppl):S42-S53
The anticarcinogenic effects and mechanisms of the biotechnological drugs of Panax ginseng C.A. Meyer cultivated in Russia, bioginseng, panaxel and panaxel- 5, were studied. Bioginseng was produced from a tissue culture of ginseng root cultured on standard medium, whereas panaxel and panaxel-5 were produced from ginseng tissue root cultures using standard mediums enriched with 2-carboxyethylgermanium sesquioxide and 1-hydroxygermatran-monohydrate respectively. All three ginseng drugs inhibited the development of mammary tumors induced by intramammary injections of N-methyl-N-nitrosourea (MNU) in rats, the development of the brain and spinal cord tumors induced by transplacental administration of N-ethyl-N-nitrosourea (ENU) in rats, and the development of uterine, cervical and vaginal tumors induced by intravaginal applications of 7,12-dimethylbenz(a)anthracene (DMBA) in mice. The ginseng drugs induced the cytotoxic activity of macrophages in mice, enhanced T-lymphocyte rosette formation in guinea pigs exposed to cyclophosphamide, and stimulated the production of thyroid hormones in rats. These mechanisms may contribute to the anticarcinogenic action of the ginseng drugs. The organic germanium compounds present in panaxel and panaxel-5 did not potentiate the anticarcinogenic or immuno- stimulatory effects as much as biogeinseng. Preliminary clinical trials with panaxel and bioginseng were carried out in patients with precancerous lesions of the esophagus and endometrium. Panaxel was found to have a strong therapeutic effect in patients suffering from chronic erosive esophagitis. Bioginseng induced the regression of adenomatous-cystic hyperplasia of the endometrium in some patients. Thus, we conclude that the drugs of ginseng appear to hold considerable promise for future cancer chemoprevention.
Adenocarcinoma/chemically induced/prevention & control
;
Adult
;
Animal
;
Antineoplastic Agents, Phytogenic/*therapeutic use
;
Cells, Cultured
;
Cervix Neoplasms/chemically induced/prevention & control
;
Clinical Trials
;
Cytotoxicity Tests, Immunologic
;
Disease Models, Animal
;
Endometrial Neoplasms/pathology/prevention & control
;
Endometrium/pathology
;
Esophageal Neoplasms/pathology/prevention & control
;
Esophagus/pathology
;
Estradiol/blood
;
Female
;
Fibroadenoma/chemically induced/prevention & control
;
Human
;
Macrophages, Peritoneal/cytology/immunology
;
Male
;
Mammary Neoplasms, Experimental/chemically induced/prevention & control
;
Mice
;
Mice, Inbred C57BL
;
Neoplasms, Experimental/chemically induced/*prevention & control
;
Nervous System Neoplasms/chemically induced/prevention & control
;
Panax/*metabolism
;
Precancerous Conditions/pathology/*prevention & control
;
Rats
;
Tissue Culture
;
Uterine Neoplasms/chemically induced/prevention & control
;
Vaginal Neoplasms/chemically induced/prevention & control
10.IL-25 blockade inhibits metastasis in breast cancer.
Zhujun JIANG ; Jingtao CHEN ; Xuemei DU ; Hang CHENG ; Xiaohu WANG ; Chen DONG
Protein & Cell 2017;8(3):191-201
Metastasis is the leading cause of death in breast cancer patients. However, the mechanisms underlying metastasis are not well understood and there is no effective treatment in the clinic. Here, we demonstrate that in MMTV-PyMT, a highly malignant spontaneous breast tumor model, IL-25 (also called IL-17E) was expressed by tumor-infiltrating CD4 T cells and macrophages. An IL-25 neutralization antibody, while not affecting primary tumor growth, substantially reduced lung metastasis. Inhibition of IL-25 resulted in decreased type 2 T cells and macrophages in the primary tumor microenvironments, both reported to enhance breast tumor invasion and subsequent metastasis to the lung. Taken together, our data suggest IL-25 blockade as a novel treatment for metastatic breast tumor.
Animals
;
Antibodies, Neoplasm
;
pharmacology
;
Antibodies, Neutralizing
;
pharmacology
;
Breast Neoplasms
;
drug therapy
;
genetics
;
immunology
;
CD4-Positive T-Lymphocytes
;
immunology
;
pathology
;
Female
;
Humans
;
Interleukin-17
;
antagonists & inhibitors
;
genetics
;
immunology
;
Interleukins
;
antagonists & inhibitors
;
genetics
;
immunology
;
Macrophages
;
immunology
;
pathology
;
Mammary Neoplasms, Animal
;
drug therapy
;
genetics
;
immunology
;
Mice
;
Neoplasm Metastasis
;
Tumor Microenvironment
;
drug effects
;
genetics
;
immunology